Adebrelimab
Adebrelimab Uses, Dosage, Side Effects, Food Interaction and all others data.
Adebrelimab is under investigation in clinical trial NCT03711305 (Study of Carboplatin Plus Etoposide With or Without SHR-1316 in Participants With Untreated Extensive-stage (ES) Small Cell Lung Cancer (SCLC)).
| Trade Name | Adebrelimab |
| Generic | Adebrelimab |
| Adebrelimab Other Names | Adebrelimab |
| Type | |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | September 19, 2023 at 7:00 am |
Innovators Monograph
You find simplified version here Adebrelimab
